triamcinolone acetonide has been researched along with Corneal Neovascularization in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, W; Chen, H; Gao, H; Huang, C; Qi, X; Wang, H | 1 |
| Dos Santos, T; Fernandes, AR; Garcia, ML; Granja, PL; Sánchez-López, E; Silva, AM; Souto, EB; Vidal, LB | 1 |
| Athanasiadis, Y; Nithyanandrajah, GA; Novitskaya, E; Sharma, A | 1 |
| Chung, SK; Kang, S | 1 |
| Lanzetta, P; Vergallo, S; Veritti, D | 1 |
| Ambati, BK; Archer, B; Cho, YK; Kompella, UB; Luo, L; Singh, N; Tyagi, P; Uehara, H; Young, JR; Zhang, X | 1 |
| Ambati, BK; Archer, B; Cho, YK; Uehara, H; Young, JR | 1 |
| Ambati, B; Archer, B; Cho, YK; Uehara, H; Young, JR; Zhang, X | 1 |
| Horiuchi, S; Murata, M; Shimizu, S; Taira, M | 1 |
| Anand-Apte, B; Ebrahem, Q; Hoppe, G; Minamoto, A; Sears, JE | 1 |
| Aydin, E; Kazi, AA; Kivilcim, M; Peyman, GA; Riazi-Esfahani, M; Sanders, DR | 1 |
| Durmus, M; Erdurmus, M | 1 |
| Aydin, B; Erdurmus, M; Hepsen, IF; Karadag, R; Turkmen, C; Yagci, R; Yilmaz, B | 1 |
| Ambati, B; Harooni, H; Reddy, V; Root, T | 1 |
| Aydin, E; Esfahani, MR; Kazi, AA; Kivilcim, M; Peyman, GA; Sanders, DR | 1 |
15 other study(ies) available for triamcinolone acetonide and Corneal Neovascularization
| Article | Year |
|---|---|
Monolith/Hydrogel composites as triamcinolone acetonide carriers for curing corneal neovascularization in mice by inhibiting the fibrinolytic system.
Topics: Animals; Cell Line; Cornea; Corneal Neovascularization; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Drug Stability; Humans; Hydrogels; Male; Mice; Mice, Inbred BALB C; Triamcinolone Acetonide | 2022 |
Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processes.
Topics: Animals; Cations; Cornea; Corneal Neovascularization; Drug Delivery Systems; Inflammation; Rabbits; Triamcinolone Acetonide; Water | 2022 |
Subconjunctival triamcinolone for the treatment of corneal graft rejection and new vessels.
Topics: Conjunctiva; Corneal Neovascularization; Corneal Transplantation; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Injections; Middle Aged; Triamcinolone Acetonide | 2009 |
The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Injections; Interleukin-6; Rabbits; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Triple therapy for corneal neovascularization: a case report.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Corneal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Graft Rejection; Humans; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2012 |
Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.
Topics: Angiogenesis Inhibitors; Animals; Corneal Neovascularization; Glucocorticoids; Graft Survival; Lymphangiogenesis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2012 |
Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model.
Topics: Animals; Corneal Neovascularization; Disease Models, Animal; Glucocorticoids; Graft Survival; Intraocular Pressure; Keratitis; Keratoplasty, Penetrating; Lymphangiogenesis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Premedication; Suture Techniques; Triamcinolone Acetonide | 2012 |
Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.
Topics: Animals; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Synergism; Female; Glucocorticoids; Graft Survival; Keratoplasty, Penetrating; Lymphangiogenesis; Lymphatic Vessels; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholinos; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2012 |
Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
Topics: Animals; Conjunctiva; Corneal Neovascularization; Drug Implants; Fibroblast Growth Factor 2; Glucocorticoids; Injections; Limbus Corneae; Rabbits; Triamcinolone Acetonide | 2006 |
Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors.
Topics: Animals; Blotting, Western; Chorioallantoic Membrane; Corneal Neovascularization; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Glucocorticoids; Interleukin-6; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Rats, Inbred F344; Receptors, Interleukin-6; Receptors, Vascular Endothelial Growth Factor; STAT3 Transcription Factor; Triamcinolone Acetonide; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |
Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
Topics: Animals; Anti-Bacterial Agents; Cornea; Corneal Neovascularization; Cyclooxygenase Inhibitors; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Fibrinolytic Agents; Flurbiprofen; Glucocorticoids; Heparin, Low-Molecular-Weight; Male; Ophthalmic Solutions; Rats; Rats, Long-Evans; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Drug delivery to the eye through systematic circulation following subconjonctival injection.
Topics: Animals; Conjunctiva; Corneal Neovascularization; Drug Implants; Fibroblast Growth Factor 2; Glucocorticoids; Injections; Limbus Corneae; Rabbits; Triamcinolone Acetonide | 2007 |
Inhibitory effects of topical thymoquinone on corneal neovascularization.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Triamcinolone Acetonide | 2007 |
Bevacizumab for graft rejection.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctiva; Corneal Neovascularization; Drug Therapy, Combination; Glucocorticoids; Graft Rejection; Humans; Injections; Keratoplasty, Penetrating; Male; Prednisolone; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2007 |
Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Corneal Neovascularization; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Hydrogen-Ion Concentration; Male; Rats; Rats, Long-Evans; Triamcinolone Acetonide | 2008 |